Labebet 100mg Tablet contains Labetalol, a non-selective beta-adrenergic receptor blocker with additional alpha-1 adrenergic receptor blocking activity, used primarily for the management of hypertension. By inhibiting beta-1 and beta-2 receptors, Labetalol reduces heart rate and myocardial contractility, leading to decreased cardiac output, while alpha-1 blockade induces vasodilation, resulting in lowered peripheral vascular resistance. This dual mechanism makes Labebet effective in controlling blood pressure without significant reflex tachycardia. It is indicated for the treatment of essential hypertension, hypertensive emergencies, and hypertension associated with pregnancy (pre-eclampsia). Labebet should be administered orally as prescribed, with dosage adjustments based on clinical response and tolerability. Common adverse effects include dizziness, fatigue, nausea, and hypotension; caution is advised in patients with asthma, bradycardia, heart block, or hepatic impairment. Monitoring of blood pressure, heart rate, and liver function tests is recommended during therapy. Labebet may interact with other antihypertensive agents, antiarrhythmics, and drugs affecting hepatic metabolism. It is contraindicated in patients with severe bradycardia, cardiogenic shock, or known hypersensitivity to Labetalol. Proper adherence to prescribed dosage and regular follow-up are essential to optimize therapeutic outcomes and minimize adverse effects.